Last Updated: November 13, 2026

Droperidol - Generic Drug Details

« Back to Dashboard


Summary for droperidol
US Patents:0
Tradenames:4
Applicants:12
NDAs:24
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 1
Clinical Trials: 46
Patent Applications: 7,144
What excipients (inactive ingredients) are in droperidol?droperidol excipients list
DailyMed Link:droperidol at DailyMed
Recent Clinical Trials for droperidol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanford UniversityEARLY_PHASE1
Universitas PadjadjaranPHASE2
University of ThessalyPHASE4

See all droperidol clinical trials

Pharmacology for droperidol
Medical Subject Heading (MeSH) Categories for droperidol
Anatomical Therapeutic Chemical (ATC) Classes for droperidol

US Patents and Regulatory Information for droperidol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca FENTANYL CITRATE AND DROPERIDOL droperidol; fentanyl citrate INJECTABLE;INJECTION 072027-001 Apr 13, 1989 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Igi Labs Inc DROPERIDOL droperidol INJECTABLE;INJECTION 072021-001 Oct 19, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Luitpold DROPERIDOL droperidol INJECTABLE;INJECTION 072335-001 Oct 24, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Igi Labs Inc DROPERIDOL droperidol INJECTABLE;INJECTION 072020-001 Oct 19, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.